Drug Type Small molecule drug |
Synonyms VP 003, VP003 |
Target |
Action antagonists |
Mechanism β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Preclinical | United Kingdom | 07 Mar 2023 |